Ethical Compliance
ERIS LIFESCIENCES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.8%
Debt
38.8%
Liquidity
19.9%
Revenue
Debt
Liquidity
0.8%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Operating Revenues | ₹17.85 |
| Other Income | ₹7.43 |
| Pharmaceutical Products | ₹1,991.30 |
Questionable
INR Crores
| Investment Gain | ₹9.38 |
Non Compliant
INR Crores
| Interest Income | ₹7.01 |
INR Crores
| Revenue from Questionable Sources: | ₹9.38 |
| Revenue from Non Compliant Sources: | ₹7.01 |
| Total: | ₹16.39 |
| Total Revenue: | ₹2,032.96 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹16.39
₹2,032.96
= 0.8%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
